Route 92 Medical Stock / Medical DevicesFounded: 2015

Route 92 Medical, founded in 2015, is a medical device company that manufactures equipment designed to help clinicians be more efficient during neurovascular interventions with the goal of improving patient results. The Route 92 products, which include the Base Camp Sheath, FreeClimb Catheter, and Tenzing Delivery Catheter, strive to provide stability and access for dispatching large-bore and super-bore catheters. Route 92 Medical is headquartered in San Mateo, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Route 92 Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Route 92 Medical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Route 92 Medical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Route 92 Medical investors also invested in these private companies


Management Team

Tony Chou MD
Co-Founder, Chief Executive Officer & President
Kirsten Valley
Chief Operating Officer
John Miller
Chief Technology Officer
Blaise Baxter MD
Chief Clinical Officer
Jonathan Kennedy
Chief Financial Officer
Christopher Hartman
Chief Commercial Officer

Board Members

Ariella Golomb MD
InnovaHealth Partners
Casper de Clercq
Norwest Venture Partners
John Runnells JD
The Vertical Group
Jonathan Root MD
US Venture Partners

Route 92 Medical’s stock FAQs


Can you buy Route 92 Medical’s stock?

Route 92 Medical is not publicly traded on NYSE or NASDAQ in the U.S. To buy Route 92 Medical’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Route 92 Medical’s stock?

Yes, you can sell stock of a private company like Route 92 Medical. Forge can help you sell your Route 92 Medical stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Route 92 Medical’s stock price?

Route 92 Medical is a privately held company and therefore does not have a public stock price. However, you may access Route 92 Medical’s private market stock price with Forge Data.

What is Route 92 Medical’s stock ticker symbol?

Route 92 Medical does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Route 92 Medical Raises Over $31M in Series F Equity Financing

Route 92 Medical, a San Mateo, CA-based medical technology company, raised over $31M in Series F funding. The round was led by existing venture capital investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. Led by CEO and Founder Tony Chou, Route 92 Medical is on a mission to improve outcomes for patients undergoing neurovascular intervention through engineering and product design.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.